IL-36 cytokines released from keratinocytes increase the immunoglobulin (Ig)E production mediated by IL-4 in B cells from AD patients and treatment with anti-IL-36R antibodies decreases IgE and alleviates the disease phenotype [50, 51]. Here, IL1RL2 is linked to Alzheimer disease.